2017 Year in Review
As we enter 2018, NYSCF is taking a moment to look back on the milestones of 2017. With your support, we accelerated our research, began new...
24 Results
Clear Filters
NYSCF and Mount Sinai Researchers Recapitulate Alzheimer’s Disease in the Laboratory
NYSCF Research Institute scientists in collaboration with researchers at the Icahn School of Medicine at Mount Sinai refined a technique to turn skin cells from patients...
A Robust, High-Throughput Protocol for Deriving Microglia From Human Stem Cells
NYSCF Research Institute scientists have developed a robust, efficient method for deriving microglia, the immune cells of the brain, from human stem cells. Microglia are increasingly...
Visual Stimulation Treats Alzheimer’s Plaques in Mice
NYSCF – Robertson Neuroscience Investigator Dr. Ed Boyden and his team at MIT Media Lab published their latest work on an exciting new, noninvasive approach to treating...
NYSCF Research Institute and Yumanity Therapeutics Announce Discovery Collaboration
The NYSCF Research Institute announced a new collaboration with Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfiling, to generate...
New Type of Stem Cells that Accelerate Discovery
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
NYSCF Quoted in The Wall Street Journal on Experimental Alzheimer’s Drug Testing
Bringing treatments out of laboratories and into clinics remains a major obstacle for healthcare. Mice and other common lab animals cannot reliably predict human responses to...
Visiting NYSCF Researcher Studies The Role of Vitamin B1 in Alzheimer’s Disease
Dr. Gary Gibson, Director of the Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration at Weill Cornell Medical College, joined NYSCF as a visiting scientist...
NYSCF Featured Speaker at Alzheimer’s Disease Conference
Dr. Scott Noggle, NYSCF Vice President for Stem Cell Research, presented NYSCF’s latest Alzheimer’s disease research as the keynote speaker at the Alzheimer’s Disease Resource Center’s...
NYSCF Travels Out East to Discuss Latest Research
In conjunction with the Alzheimer’s Disease Resource Center (ADRC), NYSCF presented their latest Alzheimer’s research at the Jewish Center of the Hamptons in East Hampton. Presentations...
NYSCF Speaks at Leading Alzheimer’s Conference
Dr. Scott Noggle, Director of the NYSCF Laboratory and NYSCF – Charles Evans Senior Research Fellow for Alzheimer’s Disease, presented the latest in Alzheimer’s research at the...
NYSCF Researchers Identify New Gene Targets in Early-Onset Alzheimer’s
NYSCF scientists, in collaboration with scientists from the Icahn School of Medicine at Mount Sinai, successfully created and used a stem cell model of familial Alzheimer’s...
NYSCF Scientists Make Living Brain Cells From Deceased Alzheimer’s Patients Biobanked Brain Tissue
NYSCF scientists, in collaboration with scientists from Columbia University Medical Center, successfully generated induced pluripotent stem cells and, subsequently, neurons from non-cryoprotected biobanked brain tissue of...
NYSCF Collaborates on Large Scale Alzheimer’s Research Program with Mount Sinai
Announced today, NYSCF will be the lead stem cell partner in an Alzheimer's consortia with scientists at Icahn School of Medicine at Mount Sinai and other...
Colombian Alzheimer’s Disease Study Reveals Changes to Brain Before Symptoms
A large, extended Colombian family gripped by early-onset Alzheimer’s disease has helped researchers led by Eric Reiman, MD, determine how early (and rapidly) changes to the...
NYSCF Scientists Develop iPS Cell Model of Alzheimer’s Disease, A Key Step to Understanding Disease
At the Alzheimer’s Association International Conference this past July, Andrew Sproul, PhD, a NYSCF Postdoctoral Associate, presented NYSCF’s latest efforts to understand Alzheimer’s disease. They have...
NYSCF Scientists Develop iPS Cell Model of Alzheimer’s Disease, A Key Step to Understanding Disease
At the Alzheimer’s Association International Conference this past July, Andrew Sproul, PhD, a NYSCF Postdoctoral Associate, presented NYSCF’s latest efforts to understand Alzheimer’s disease. They have...
NYSCF Scientists Featured at Alzheimer’s Association International Conference For New Alzheimer’s Disease Model
A team of scientists at The New York Stem Cell Foundation (NYSCF) Laboratory led by Scott Noggle, PhD, NYSCF–Charles Evans Senior Research Fellow for Alzheimer’s Disease,...
NYSCF and Harvard Stem Cell Institute to Collaborate on Drug Discovery
New York Stem Cell Foundation, Harvard Stem Cell Institute Announce Joint Effort to Accelerate Drug Discovery NEW YORK, N.Y. (Nov. 17, 2011) — The New York...
Interview with NYSCF Fellow Chris Fasano
NYSCF Fellow Dr. Christopher Fasano recently published a paper in which he was able to create floor plate tissue from human embryonic stem cells (hESCs). This...
Alzheimer’s Disease: How Stem Cell Research Will Make A Difference
The New York Stem Cell Foundation (NYSCF) held its fifth annual spring public outreach event on Thursday, March 25 at The TimesCenter in New York City....
The Puzzling Rise and Fall of a Dark-Horse Alzheimer’s Drug
Science, News “The announcement last week that a closely watched phase III clinical trial for Alzheimer’s disease had failed to show a significant effect deals yet...
The Stem Cell Wars Are Not Over
First appeared in The Huffington Post Nothing would give the millions of people afflicted with heart disease, diabetes, cancer, Parkinson’s disease, Alzheimer’s disease and spinal cord...
NYSCF Responds to New Jersey Stem Cell Vote
The New York Stem Cell Foundation expresses its disappointment in the state of New Jersey for voting “no” on the Stem Cell Research Bond Act ballot...